Locating Mammalian Transcription Factor Binding Sites: a Survey of Computational and Experimental Techniques
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
DNA Footprinting with an Automated DNA Analyzer: Does the Shoe Fit?
DNA Footprinting with an automated DNA Analyzer: does the shoe fit? Michael Zianni Manager, Plant-Microbe Genomics Facility DNA Footprinting with an Applied Biosystems 3730 DNA Analyzer: does the shoe fit ……….yes! DNA Footprint Analysis DNA Fragment BSA 6FAM DNA Binding Protein 6FAM Endonuclease Digestion (DNase I) 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM Capillary Electrophoresis rfu rfu Size (bp) Size (bp) 6FAM HrpY DNA Fragment 6FAM BSA 6FAM HrpY DNA Fragment 6FAM BSA Endonuclease EndonucleaseDigestion (DNaseDigestion I) (DNase I) 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM 6FAM Capillary ElectrophoresisCapillary Electrophoresis rfu rfu rfu rfu Size (bp) Size (bp) Size (bp) Size (bp) Development of DNA Foot print Analysis Techniques and Goals of This Study First performed in 1977, and utilized radioactively labeled DNA, slab gels, and autoradiography In 1994, dyes and fluorescent gel imager were used instead of radioisotopes and autoradiography but the slab gel remained. In 2000, the slab gel and imager were replaced by an automated capillary electrophoresis instrument: 310 DNA Analyzer. In 2004, ........... Demonstrate the feasibility by reproducing a protection assay previously done with autoradiography and a slab gel Demonstrate that each peak could be accurately identified Apply this method to a previously uncharacterized protein DNA Footprint analysis with protein: Autoradiography vs Electropherogram DNA Footprint analysis without protein: Electropherogram vs Autoradiography Fluorescent Primer Design For use in: (1) the DNA sequencing reactions which act as a standard/ladder and (2) the PCR reaction to make the DNA probe Used routine DNA sequencing guidelines: 18 -25mer. Tm at 55 – 60C. about 50% GC. -
Specificity Landscapes Unmask Submaximal Binding Site Preferences of Transcription Factors
Specificity landscapes unmask submaximal binding site preferences of transcription factors Devesh Bhimsariaa,b,1, José A. Rodríguez-Martíneza,2, Junkun Panc, Daniel Rostonc, Elif Nihal Korkmazc, Qiang Cuic,3, Parameswaran Ramanathanb, and Aseem Z. Ansaria,d,4 aDepartment of Biochemistry, University of Wisconsin–Madison, Madison, WI 53706; bDepartment of Electrical and Computer Engineering, University of Wisconsin–Madison, Madison, WI 53706; cDepartment of Chemistry, University of Wisconsin–Madison, Madison, WI 53706; and dThe Genome Center of Wisconsin, University of Wisconsin–Madison, Madison, WI 53706 Edited by Michael Levine, Princeton University, Princeton, NJ, and approved September 24, 2018 (received for review July 13, 2018) We have developed Differential Specificity and Energy Landscape Here, we report the development of Differential Specificity (DiSEL) analysis to comprehensively compare DNA–protein inter- and Energy Landscapes (DiSEL) to compare experimental actomes (DPIs) obtained by high-throughput experimental plat- platforms, computational methods, and interactomes of TFs, forms and cutting edge computational methods. While high-affinity especially those factors that bind identical consensus motifs. Our DNA binding sites are identified by most methods, DiSEL uncovered results reveal that (i) most high-throughput experimental plat- nuanced sequence preferences displayed by homologous transcription forms reliably identify high-affinity motifs but yield less reliable factors. Pairwise analysis of 726 DPIs uncovered homolog-specific dif- information on submaximal sites; (ii) with few exceptions, com- ferences at moderate- to low-affinity binding sites (submaximal sites). putational methods model DPIs with a focus on high-affinity DiSEL analysis of variants of 41 transcription factors revealed that sites; (iii) submaximal sites improve the annotation of biologi- many disease-causing mutations result in allele-specific changes in cally relevant binding sites across genomes; (iv) among members binding site preferences. -
What Would You Do If You Could Sequence Everything?
PERspECTIVE What would you do if you could sequence everything? Avak Kahvejian1, John Quackenbush2 & John F Thompson1 It could be argued that the greatest transformative aspect ing technologies, be leveraged with insightful approaches to biology and of the Human Genome Project has been not the sequencing medicine to maximize the benefits to all? DNA sequence is no longer just of the genome itself, but the resultant development of new an end in itself, but it is rapidly becoming the digital substrate replac- technologies. A host of new approaches has fundamentally ing analog chip-based hybridization signals; it is the barcode tracking of changed the way we approach problems in basic and enormous numbers of samples; and it is the readout indicating a host of translational research. Now, a new generation of high-throughput chemical modifications and intermolecular interactions. Sequence data sequencing technologies promises to again transform the allow one to count mRNAs or other species of nucleic acids precisely, to scientific enterprise, potentially supplanting array-based determine sharp boundaries for interactions with proteins or positions technologies and opening up many new possibilities. By allowing of translocations and to identify novel variants and splice sites, all in one http://www.nature.com/naturebiotechnology DNA/RNA to be assayed more rapidly than previously possible, experiment with digital accuracy. these next-generation platforms promise a deeper understanding The brief history of molecular biology and genomic technologies has of genome regulation and biology. Significantly enhancing been marked by the introduction of new technologies, their rapid uptake sequencing throughput will allow us to follow the evolution and then a steady state or slow decline in use as newer techniques are of viral and bacterial resistance in real time, to uncover the developed that supersede them. -
DNA Binding Site of the Growth Factor-Inducible Protein Zif268
Proc. Natl. Acad. Sci. USA Vol. 86, pp. 8737-8741, November 1989 Biochemistry DNA binding site of the growth factor-inducible protein Zif268 ("zinc fingers"/transcription factor/cell growth) BARBARA CHRISTY AND DANIEL NATHANS* Howard Hughes Medical Institute and the Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21205 Contributed by Daniel Nathans, August 31, 1989 ABSTRACT Zif268, a zinc finger protein whose mRNA is The recombinant plasmid was transfected into E. coli strain rapidly activated in cells exposed to growth factors or other BL21(DE3) and the transfected cells were grown as described signaling agents, is thought to play a role in regulating the (22) to an optical density of about 0.6 before induction of T7 genetic program induced by extracellular ligands. We report RNA polymerase with 0.4 mM isopropyl B-D-thiogalacto- that Zif268 has one of the characteristics of a transcriptional pyranoside (IPTG). Bacterial extracts used for DNA binding regulator, namely, sequence-specific binding to DNA. Zif268 were prepared as described (23). After solubilization of synthesized in Escherichia coli bound to two sites upstream of proteins with 4 M urea the preparation was dialyzed against the zif268 gene and to sites in the promoter regions of other 20 mM Tris, pH 7.7/50 mM KCI/10 mM MgCl2/i mM genes. The nucleotide sequences responsible for binding were EDTA/10 ,uM ZnSO4/20% (vol/vol) glycerol/1 mM dithio- defined by DNase I footprinting, by methylation interference threitol/0.2 mM phenylmethylsulfonyl fluoride/1 mM so- experiments, and by use of synthetic oligonucleotides. -
DNA Affinity Labeling of Adenovirus Type 2 Upstream Promoter Sequence-Binding Factors Identifies Two Distinct Proteins BRIAN SAFER,* ROGER B
MOLECULAR AND CELLULAR BIOLOGY, Jan. 1988, p. 105-113 Vol. 8, No. 1 0270-7306/88/010105-09$02.00/0 Copyright © 1988, American Society for Microbiology DNA Affinity Labeling of Adenovirus Type 2 Upstream Promoter Sequence-Binding Factors Identifies Two Distinct Proteins BRIAN SAFER,* ROGER B. COHEN, SUSAN GARFINKEL, AND JOHN A. THOMPSON Section on RNA and Protein Biosynthesis, Laboratory of Molecular Hematology, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892 Received 14 July 1987/Accepted 14 October 1987 A rapid affinity labeling procedure with enhanced specificity was developed to identify DNA-binding proteins. 32p was first introduced at unique phosphodiester bonds within the DNA recognition sequence. UV light-dependent cross-linking of pyrimidines to amino acid residues in direct contact at the binding site, followed by micrococcal nuclease digestion, resulted in the transfer of 32p to only those specific protein(s) which recognized the binding sequence. This method was applied to the detection and characterization of proteins that bound to the upstream promoter sequence (-50 to -66) of the human adenovirus type 2 major late promoter. We detected two distinct proteins with molecular weights of 45,000 and 116,000 that interacted with this promoter element. The two proteins differed significantly in their chromatographic and cross-linking behaviors. The accurate and regulated expression of genes tran- sequence (UPS) of the adenovirus type 2 (Ad2) major late scribed by RNA polymerase II requires the interaction of promoter (MLP). Results of deletion and mutation analyses specific DNA-binding proteins with cis-acting promoter ele- have shown that efficient transcription of the Ad2 MLP is ments (2, 10, 14, 29, 36). -
Direct Inhibition of the DNA-Binding Activity of POU Transcription Factors
Published online 25 April 2008 Nucleic Acids Research, 2008, Vol. 36, No. 10 3341–3353 doi:10.1093/nar/gkn208 Direct inhibition of the DNA-binding activity of POU transcription factors Pit-1 and Brn-3 by selective binding of a phenyl-furan-benzimidazole dication Paul Peixoto1,2, Yang Liu3, Sabine Depauw1,2, Marie-Paule Hildebrand1,2,4, David W. Boykin3, Christian Bailly1,2, W. David Wilson3 and Marie-He´ le` ne David-Cordonnier1,2,* Downloaded from https://academic.oup.com/nar/article/36/10/3341/2410535 by guest on 23 September 2021 1INSERM U-837, Team 4-‘Molecular and cellular targeting for cancer treatment’, Jean-Pierre Aubert Research Center, Institut de Recherches sur le Cancer de Lille, Place de Verdun, F-59045 Lille, 2IMPRT-IFR114, Lille, France, 3Department of Chemistry, Georgia State University, Atlanta, GA, USA and 4Institut de Recherches sur le Cancer de Lille - IRCL, Lille, France Received February 5, 2008; Revised and Accepted April 8, 2008 ABSTRACT control of transcription factors activity by those The development of small molecules to control gene compounds. expression could be the spearhead of future- targeted therapeutic approaches in multiple pathol- ogies. Among heterocyclic dications developed with INTRODUCTION this aim, a phenyl-furan-benzimidazole dication The aim of exerting precise control over the expression DB293 binds AT-rich sites as a monomer and level of specified genes using a small molecule drug is an ’ 5 -ATGA sequence as a stacked dimer, both in the objective with major consequences for many therapeutic minor groove. Here, we used a protein/DNA array applications including cancer, chronic inflammatory dis- approach to evaluate the ability of DB293 to specif- orders, neuro-degenerative or cardiovascular diseases ically inhibit transcription factors DNA-binding in a (1–4). -
Input Template Epg Pathshala
Paper : 15 Molecular Cell Biology Module : 34 Methods for analysis of gene expression: Promoter analysis, DNA foot printing Development Team Principal Investigator: Prof. Neeta Sehgal Department of Zoology, University of Delhi Co-Principal Investigator: Prof. D.K. Singh Department of Zoology, University of Delhi Paper Coordinator: Prof. Kuldeep K. Sharma Department of Zoology, University of Jammu Content Writer: Dr. Jasvinder Kaur, Dr. Poonam Sharma Gargi College, University of Delhi Ms Poornima Vishwakarma, Research Scholar, DU Content Reviewer: Prof. Rup Lal Department of Zoology, University of Delhi 1 ZOOLOGY Molecular Cell biology Methods for analysis of gene expression: Promoter analysis, DNA foot printing Description of Module Subject Name ZOOLOGY Paper Name Zool 015: Molecular Cell Biology Module Name/Title Methods for analysis of gene expression Module ID M34: Promoter analysis, DNA foot printing Keywords DNA Footprint Assay, DNase I, DNA foot print, Promoter characterization, Cleavage agent, Autoradiography Glossary Capillary electrophoresis: To modify the footprinting procedure to modernized detection means, the labelled DNA fragments are identified using capillary electrophoresis mechanism as a substitute of polyacrylamide gel DNase I: A DNA- hydrolyzing enzyme that cuts DNA at random locations in a sequence independent manner DNA Footprint Assay: Technique used to determine the binding site of a protein regulator to DNA which is typically at a promoter for a gene. Foot print: The protected DNA region (bound by proteins) in a DNA footprinting experiment. Hydroxyl radicals: When the iron salts are reacted with hydrogen peroxide, they are reduced to form free hydroxyl radicals. The DNA fragment is cleaved when the free hydroxyl molecule react with the DNA backbone. -
Preferences in a Trait Decision Determined by Transcription Factor Variants
Preferences in a trait decision determined by transcription factor variants Michael W. Dorritya,b, Josh T. Cuperusa,c, Jolie A. Carlislea, Stanley Fieldsa,c,d,1, and Christine Queitscha,1 aDepartment of Genome Sciences, University of Washington, Seattle, WA 98195; bDepartment of Biology, University of Washington, Seattle, WA 98195; cHoward Hughes Medical Institute, University of Washington, Seattle, WA 98195; and dDepartment of Medicine, University of Washington, Seattle, WA 98195 Contributed by Stanley Fields, June 27, 2018 (sent for review April 9, 2018; reviewed by Leah E. Cowen and Andrew W. Murray) Few mechanisms are known that explain how transcription factors mating, Ste12 can bind at pheromone-responsive genes as a can adjust phenotypic outputs to accommodate differing environ- homodimer or with the cofactors Mcm1 or Matα1 (10–13). The ments. In Saccharomyces cerevisiae, the decision to mate or invade consensus DNA-binding site of Ste12 is TGAAAC, known as the relies on environmental cues that converge on a shared transcription pheromone response element (PRE) (11). For invasion, Ste12 factor, Ste12. Specificity toward invasion occurs via Ste12 binding and its cofactor Tec1 are both required to activate genes that me- cooperatively with the cofactor Tec1. Here, we determine the range diate filamentation (8, 14, 15). Some of these genes contain a of phenotypic outputs (mating vs. invasion) of thousands of DNA- Ste12 binding site near a Tec1 consensus sequence of GAATGT, an binding domain variants in Ste12 to understand how preference for organization for heterodimeric binding known as a filamentation invasion may arise. We find that single amino acid changes in the response element (FRE). -
Chromatin Accessibility and the Regulatory Epigenome
REVIEWS EPIGENETICS Chromatin accessibility and the regulatory epigenome Sandy L. Klemm1,4, Zohar Shipony1,4 and William J. Greenleaf1,2,3* Abstract | Physical access to DNA is a highly dynamic property of chromatin that plays an essential role in establishing and maintaining cellular identity. The organization of accessible chromatin across the genome reflects a network of permissible physical interactions through which enhancers, promoters, insulators and chromatin-binding factors cooperatively regulate gene expression. This landscape of accessibility changes dynamically in response to both external stimuli and developmental cues, and emerging evidence suggests that homeostatic maintenance of accessibility is itself dynamically regulated through a competitive interplay between chromatin- binding factors and nucleosomes. In this Review , we examine how the accessible genome is measured and explore the role of transcription factors in initiating accessibility remodelling; our goal is to illustrate how chromatin accessibility defines regulatory elements within the genome and how these epigenetic features are dynamically established to control gene expression. Chromatin- binding factors Chromatin accessibility is the degree to which nuclear The accessible genome comprises ~2–3% of total Non- histone macromolecules macromolecules are able to physically contact chroma DNA sequence yet captures more than 90% of regions that bind either directly or tinized DNA and is determined by the occupancy and bound by TFs (the Encyclopedia of DNA elements indirectly to DNA. topological organization of nucleosomes as well as (ENCODE) project surveyed TFs for Tier 1 ENCODE chromatin- binding factors 13 Transcription factor other that occlude access to lines) . With the exception of a few TFs that are (TF). A non- histone protein that DNA. -
Genome-Scale Technologies 2/ Algorithmic and Statistical Aspects of DNA Sequencing Dnase I-Seq
Genome-scale technologies 2/ Algorithmic and statistical aspects of DNA sequencing DNase I-seq Ewa Szczurek University of Warsaw, MIMUW [email protected] Deoxyribonuclease I (DNase I) § cleaves DNA adjacent to a pyrimidine nucleotide. § a waste-management endonuclease § one of the deoxyribonucleases responsible for DNA fragmentation during apoptosis. § DNase I hypersensitive sites ~ Ø open, accessible chromatin; Ø regions of the genome are likely to contain active genes Ho-Ryun Chung The project § http://students.mimuw.edu.pl/~szczurek/TSG2_Project/project.html § Report deadline: 20.01.2016 § Presentations: 26.01.2016 Deoxyribonuclease I (DNase I) hypersensitive sites § Short region of chromatin. § Super sensitivity to Dnase I cleavage § Nucleosomal structure less compacted § Increased availability of the DNA to binding by proteins: Ø transcription factors and Ø DNase I "DNAse hypersensitive site" by Wang Y-M, Zhou P, Wang L-Y, Li Z-H, Zhang Y-N, et al. - Wang Y-M, Zhou P, Wang L-Y, Li Z-H, Zhang Y-N, et al. (2012) Correlation Between DNase I Hypersensitive Site Distribution and Gene Expression in HeLa S3 Cells. PLoS ONE 7(8): e42414. doi:10.1371/journal.pone.0042414. DNase I hypersensitive sites: location § Hypersensitive sites (HS) found: Ø On every active gene (often >1 HS per gene) Ø Exclusively on chromatin of cells in which the gene is expressed Ø Before transcription begins, in regions preceding active promoters. § HS generated as a result of the binding of transcription factors that displace histone octamers. DNase I- Seq DNase-seq: a high-resolution technique for mapping active gene regulatory elements across the genome from mammalian cells Lingyun Song and Gregory E. -
A STAT Protein Domain That Determines DNA Sequence Recognition Suggests a Novel DNA-Binding Domain
Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain Curt M. Horvath, Zilong Wen, and James E. Darnell Jr. Laboratory of Molecular Cell Biology, The Rockefeller University, New York, New York 10021 Statl and Stat3 are two members of the ligand-activated transcription factor family that serve the dual functions of signal transducers and activators of transcription. Whereas the two proteins select very similar (not identical) optimum binding sites from random oligonucleotides, differences in their binding affinity were readily apparent with natural STAT-binding sites. To take advantage of these different affinities, chimeric Statl:Stat3 molecules were used to locate the amino acids that could discriminate a general binding site from a specific binding site. The amino acids between residues -400 and -500 of these -750-amino-acid-long proteins determine the DNA-binding site specificity. Mutations within this region result in Stat proteins that are activated normally by tyrosine phosphorylation and that dimerize but have greatly reduced DNA-binding affinities. [Key Words: STAT proteins; DNA binding; site selection] Received January 6, 1995; revised version accepted March 2, 1995. The STAT (signal transducers and activators if transcrip- Whereas oligonucleotides representing these selected se- tion) proteins have the dual purpose of, first, signal trans- quences exhibited slight binding preferences, the con- duction from ligand-activated receptor kinase com- sensus sites overlapped sufficiently to be recognized by plexes, followed by nuclear translocation and DNA bind- both factors. However, by screening different natural ing to activate transcription (Darnell et al. -
Inhibition of DNA Binding of the NF-Y Transcription Factor by the Pyrrolobenzodiazepine-Polyamide Conjugate GWL-78
1319 Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78 Minal Kotecha,1 Jerome Kluza,1 Geoff Wells,2 p53. Thus, agents such as GWL-78 may be useful in C. Caroline O’Hare,1 Claudia Forni,3 modulating transcription and blocking cellular proliferation. Roberto Mantovani,3 Philip W. Howard,2 [Mol Cancer Ther 2008;7(5):1319–28] Peter Morris,1 David E. Thurston,2 John A. Hartley,1 and Daniel Hochhauser1 Introduction DNA-interactive drugs are widely used in the treatment of 1 Cancer Research UK Drug-DNA Interactions Research Group, human cancers. There is considerable evidence of preferred UCL Cancer Institute, University College London; 2Cancer Research UK Gene Targeted Drug Design Research Group, School DNA sequences to which several of these agents bind. For of Pharmacy, University of London, London, United Kingdom; example, doxorubicin has been shown to bind preferen- and 3Dipartimento di Scienze Biomolecolari e Biotecnologie, tially to the CAAT quartet sequence and to the alternating Universita degli Studi di Milano, Milan, Italy polynucleotide d(TATATA)2 (1). However, the ability of these agents to recognize specific DNA sequences has not Abstract been previously considered a significant factor in their anticancer activity. It would be useful therapeutically to Many genes involved in cell cycle control have promoters develop drugs capable of inhibiting transcription factors. that bind the heterotrimeric transcription factor NF-Y. Such agents could be used to modulate chemosensitivity Several minor-groove binding drugs have been shown to by overcoming resistance mechanisms such as reduced block interactions of transcription factors with cognate expression of topoisomerase IIa (topo IIa; ref.